I applaud the committee for beginning the process of reviewing what has been accomplished by the unprecedented steps made by the by the administration.
Editor's note · Context
Bucshon supports reviewing telehealth advancements made during the pandemic.
Share & report
More from Larry Bucshon
Eliminating just one new drug is one drug too many. What if one of those new drugs is a cure for Alzheimer's, cancer, or ALS?
As I have mentioned, this will not only save lives, but will stimulate economic activity across the central part of the United States.
Instead of rushing to yet another partisan costly and duplicative package through the process, we should all be working with the Biden administration to implement the appropriations from the Energy Act of 2020.
I am concerned about the drug pricing protocols in the Build Back Better Act, and they would have the opposite effect limiting research and hampering innovation, in my view.





